WALTHAM, Mass.--(BUSINESS WIRE)--Trinity Life Sciences, the leader in strategy, insights and analytics for the life sciences industry, delivers life science companies industry-specific data ...

In conversation with Fierce Pharma, Anthony Billinger, senior director of Compass Strategy at Veeva Systems, sheds light on the rapidly evolving world of commercial data in life sciences—and why the ...

Generative AI-driven analytics platform brings together owned and public data with Oracle Health Real-World Data's millions of de-identified longitudinal EHR records Delivers powerful, deep insights ...

Wave Life Sciences presented promising preclinical data at the American Diabetes Association's 85th Annual Scientific Sessions, highlighting WVE-007, a GalNAc-siRNA therapy targeting INHBE as a ...

Management indicated they "plan to deliver multiple near-term updates that assess blood-based biomarkers of metabolic health, body composition and weight loss across multiple cohorts." Data from the ...

NashBio, a pioneer in genomics and real-world data, is transforming life sciences research by making complex healthcare data more accessible. Co-founded by Leeland Ekstrom, NashBio leverages ...

The future of healthcare is here—and it’s digital. From accelerating research to improving patient care, the integration of AI, data analytics and cutting-edge technologies is driving the industry ...

Life sciences commercial teams are drowning in data complexity. Despite having access to sophisticated analytics platforms, teams still spend days navigating multiple dashboards, waiting for insights, ...

The Case Western Reserve University School of Medicine and Case School of Engineering, in collaboration with Tohoku University (Japan), invite members of the community to the sixth annual Data Science ...

Following a single subcutaneous 240 mg dose, WVE-007 (INHBE GalNAc-siRNA) improved body composition at three months compared to baseline, with a 9.4% reduction in visceral fat (p=0.02), a 4.5% ...

Hello, and welcome to Wave Life Sciences Positive Interim Clinical Data from INLIGHT Trial of WVE-007 and Obesity call. [Operator Instructions]. Also, as a reminder, this conference is being recorded ...